" Since LL didn't beat saline "
Actually this is not a fact , below are facts..
Leronlimab was compare in CD12 to SOC drugs , drugs chosen by Dr Fauci and FDA as a best drugs in the world to treat COVID.
And even in sabotaged by FDA study , CD12 , when only 2 doses was allowed instead of 4 , results were amazing with mortality benefit with patients.
With dosing at 0 and 7 days , results :
--At 7 days, 78% mortality benefit with leronimab above all SOC drugs.
--At 14 days 82%
Here saturation of leronlimab started to go down , since 2 more doses were needed and refused to be approve by FDA , so:
--At 21 days 50% mortality benefit above SOC drugs,
--At 28 days 31%
But even 31% mortality benefit above all SOC drugs shows us how
many more lives could be saved in USA if only leronlimab will be chosen as a SOC drug.
We have vaccinations since December 2020 , and already in 2021 more people died from COVID , then in entire 2020 , why is that ?
We have vaccinations and drugs for treatment approved , remdesivir , tocilizumab , baricitinib , so why more died 2021 from covid then in entire 2020.
It is finally time for approval only drug working well for covid , and without one serious side effects.
750,000 death Americans telling us it is time.
All imo.